SCHEMBL17204366

SCHEMBL17204366

CCOC(=O)c1c(O)cc(Cc2cccc(OC)c2)[nH]c1=O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 5/20 0.58
PTGES O14684 4/20 0.58
KDM4E B2RXH2 2/20 0.53
TDP1 Q9NUW8 2/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
POLB P06746 1/20 0.48
CYP3A4 P08684 1/20 0.47
HPGD P15428 1/20 0.47
ALDH1A1 P00352 1/20 0.46
MEN1 O00255 1/20 0.46
NPC1 O15118 1/20 0.46
MAPT P10636 1/20 0.46
MAPK1 P28482 1/20 0.46
CASP3 P42574 1/20 0.46
RAB9A P51151 1/20 0.46
KMT2A Q03164 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
SENP8 Q96LD8 1/20 0.46
SENP7 Q9BQF6 1/20 0.46
SENP6 Q9GZR1 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17204571 0.80 KDM4E (0.53) ALOX5KDM4EALDH1A1KMT2AMMP2
SCHEMBL20095078 0.79 KDM4E (0.58) ALOX5PTGESKDM4EALDH1A1MAPT
SCHEMBL17204992 0.77 KDM4E (0.55) ALOX5KDM4ETDP1CYP3A4ALDH1A1
SCHEMBL1061985 0.76 KDM4E (0.72) KDM4ETDP1L3MBTL1CYP3A4HPGD
SCHEMBL1061682 0.74 KDM4E (0.68) KDM4ETDP1L3MBTL1CYP3A4HPGD
SCHEMBL22272865 0.74 PTGES (0.53) ALOX5PTGESKDM4ETDP1L3MBTL1
SCHEMBL4338584 0.74 ALOX5 (1.00) ALOX5PTGESCYP3A4ALDH1A1MEN1
SCHEMBL17204641 0.72 GPR84 (0.52) MMP1MMP2MMP9MMP12KDM4C
SCHEMBL11841940 0.72 KDM4C (0.58) KDM4EPOLBALDH1A1MEN1RAB9A
SCHEMBL6600286 0.71 LOXL2 (0.50) POLBMEN1MAPTCASP3KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111620870-B Compound and application thereof in expansion of hematopoietic stem cells and/or hematopoietic progenitor cells 蒙特利尔大学 2023-01-03 CN disclosed
CN-111620870-A Compound and application thereof in expansion of hematopoietic stem cells and/or hematopoietic progenitor cells 蒙特利尔大学 2020-09-04 CN disclosed
CN-106414445-B Compound and application thereof in expansion of hematopoietic stem cells and/or hematopoietic progenitor cells 蒙特利尔大学 2020-07-03 CN disclosed
US-10647718-B2 Compounds and use thereof in the expansion of hematopoietic stem cells and/or hematopoietic progenitor cells Universitéde Montréal (CA) 2020-05-12 US disclosed
US-10647718-B2 Compounds and use thereof in the expansion of hematopoietic stem cells and/or hematopoietic progenitor cells Universitéde Montréal (CA) 2020-05-12 US disclosed
EP-3134409-B1 COMPOUNDS AND USE THEREOF IN THE EXPANSION OF HEMATOPOIETIC STEM CELLS AND/OR HEMATOPOIETIC PROGENITOR CELLS UNIV MONTREAL (CA) 2020-02-12 EP disclosed
EP-3134409-B1 COMPOUNDS AND USE THEREOF IN THE EXPANSION OF HEMATOPOIETIC STEM CELLS AND/OR HEMATOPOIETIC PROGENITOR CELLS UNIV MONTREAL (CA) 2020-02-12 EP disclosed
EP-3134409-A1 COMPOUNDS AND USE THEREOF IN THE EXPANSION OF HEMATOPOIETIC STEM CELLS AND/OR HEMATOPOIETIC PROGENITOR CELLS Université de Montréal (CA) 2017-03-01 EP disclosed
US-20170037047-A1 COMPOUNDS AND USE THEREOF IN THE EXPANSION OF HEMATOPOIETIC STEM CELLS AND/OR HEMATOPOIETIC PROGENITOR CELLS UNIVERSITE DE MONTREAL (CA) 2017-02-09 US disclosed
US-20170037047-A1 COMPOUNDS AND USE THEREOF IN THE EXPANSION OF HEMATOPOIETIC STEM CELLS AND/OR HEMATOPOIETIC PROGENITOR CELLS UNIVERSITE DE MONTREAL (CA) 2017-02-09 US disclosed
US-20170037047-A1 COMPOUNDS AND USE THEREOF IN THE EXPANSION OF HEMATOPOIETIC STEM CELLS AND/OR HEMATOPOIETIC PROGENITOR CELLS UNIVERSITE DE MONTREAL (CA) 2017-02-09 US disclosed
WO-2015161373-A1 COMPOUNDS AND USE THEREOF IN THE EXPANSION OF HEMATOPOIETIC STEM CELLS AND/OR HEMATOPOIETIC PROGENITOR CELLS Université de Montréal (CA) 2015-10-29 WO disclosed
WO-2015161373-A1 COMPOUNDS AND USE THEREOF IN THE EXPANSION OF HEMATOPOIETIC STEM CELLS AND/OR HEMATOPOIETIC PROGENITOR CELLS Université de Montréal (CA) 2015-10-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10647718-B2 Compounds and use thereof in the expansion of hematopoietic stem cells and/or hematopoietic progenitor cells HPGDS, HCLS1, THPO ALOX5 1051/4885PTGES 1377/4885KDM4E 1764/4885
US-20170037047-A1 COMPOUNDS AND USE THEREOF IN THE EXPANSION OF HEMATOPOIETIC STEM CELLS AND/OR HEMATOPOIETIC PROGENITOR CELLS HPGDS, HCLS1, THPO ALOX5 1051/4885PTGES 1377/4885KDM4E 1764/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.